U.K. says AstraZeneca alternative should be offered for under 30s, and E.U. finds a ‘possible link’ to rare clots.
By BY BENJAMIN MUELLER, MONIKA PRONCZUK AND MATINA STEVIS-GRIDNEFF via NYT World https://ift.tt/2PJhRz1
Subscribe to:
Post Comments
(
Atom
)
Post a Comment